In vitro effectiveness of colistin, tigecycline and levofloxacin alone and combined with clarithromycin and/or heparin as lock solutions against embedded Acinetobacter baumannii strains

Journal of Antimicrobial Chemotherapy

Volumn 68, Issue 4, 2013, Pages 827-830

  Ozbek, Berna ^a   Mataraci, Emel ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Antibiotic therapy; Bacterial biofilms; Catheter related infections; Gram negatives; Polymyxin B

Indexed keywords

CLARITHROMYCIN; COLISTIN; HEPARIN; LEVOFLOXACIN; TIGECYCLINE;

ACINETOBACTER BAUMANNII; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL STRAIN; BACTERICIDAL ACTIVITY; CONTROLLED STUDY; DRUG EFFICACY; DRUG STABILITY; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION;

ACINETOBACTER BAUMANNII; ANTI-BACTERIAL AGENTS; ANTICOAGULANTS; BIOFILMS; CATHETERS; DRUG SYNERGISM; HUMANS;

EID: 84875258743     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dks472     Document Type: Article

References (20)

1. Manian FA. IDSA guidelines for the diagnosis and management of intravascular catheter-related bloodstream infection. Clin Infect Dis 2009; 49: 1770-1; author reply 1771-2.
2. Berrington A, Gould FK. Use of antibiotic locks to treat colonized central venous catheters. J Antimicrob Chemother 2001; 48: 597-603.
3. Bestul MB, Vandenbussche HL. Antibiotic lock technique: review of the literature. Pharmacotherapy 2005; 25: 211-27.
4. Fortún J, Grill F, Marti{dotless}́n-Dá vila P et al. Treatment of long-term intravascular catheter-related bacteraemia with antibiotic-lock therapy. J Antimicrob Chemother 2006; 58: 816-21.
5. Fätkenheuer G, Cornely O, Seifert H. Clinical management of catheter-related infections. Clin Microbiol Infect 2002; 8: 545-50.
6. Hanna H, Afif C, Alakech B. Central venous catheter-related bacteraemia due to gram-negative bacilli: significance of catheter removal in preventing relapse. Infect Control Hosp Epidemiol 2004; 25: 646-9.
7. Krishnasami Z, Carlton D, Bimbo L et al. Management of hemodialysis catheter-related bacteraemia with an adjunctive antibiotic lock solution. Kidney Int 2002; 61: 1136-42.
8. Schaberg DR, Culver DH, Gaynes RP. Major trends in the microbial etiology of nosocomial infection. Am J Med 1991; 91: 72-5.
9. Wisplinghoff H, Bischoff T, Tallent SM. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis 2004; 39: 309-17.
10. Levin AS, Barone AA, Penço J. Intravenous colistin as therapy for nosocomial infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii. Clin Infect Dis 1999; 28: 1008-11.
11. Seifert H, Strate A, Pulverer G. Nosocomial bacteraemia due to Acinetobacter baumannii. Clinical features, epidemiology, and predictors of mortality. Medicine (Baltimore) 1995; 74: 340-9.
12. Clinical and Laboratory Standards Institute. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically- Eighth Edition: Approved Standard M07-A8. CLSI, Wayne, PA, USA, 2009.
13. Aslam S, Trautner BW, Ramanathan V et al. Combination of tigecycline and N-acetylcysteine reduces biofilm-embedded bacteria on vascular catheters. Antimicrob Agents Chemother 2007; 51: 1556-8.
14. Funalleras G, Fernández-Hidalgo N, Borrego A et al. Effectiveness of antibiotic-lock therapy for long-term catheter-related bacteraemia due to Gram-negative bacilli: a prospective observational study. Clin Infect Dis 2011; 53: e129-32.
15. Peck KR, Kim SW, Jung SI et al. Antimicrobials as potential adjunctive agents in the treatment of biofilm infections with Staphylococcus epidermidis. Chemotherapy 2003; 49: 189-93.
16. Yamasaki O, Akiyama H, Toi Y et al. A combination of roxithromycin and imipenem as an antimicrobial strategy against biofilm formed by Staphylococcus aureus. J Antimicrob Chemother 2001; 48: 573-7.
17. Yasuda H, Ajiki Y, Koga T et al. Interaction between clarithromycin and biofilms formed by Staphylococcus epidermidis. Antimicrob Agents Chemother 1994; 38: 138-41.
18. Kandemir O, Oztuna V, Milcan A et al. Clarithromycin destroys biofilms and enhances bactericidal agents in the treatment of Pseudomonas aeruginosa osteomyelitis. Clin Orthop Relat Res 2005; 430: 171-5.
19. Capdevila JA, Gavaldà J, Fortea J et al. Lack of antimicrobial activity of sodium heparin for treating experimental catheter-related infection due to Staphylococcus aureus using the antibiotic-lock technique. Clin Microbiol Infect 2001; 7: 206-12.
20. Robinson JL, Tawfik G, Saxinger L et al. Stability of heparin and physical compatibility of heparin/antibiotic solutions in concentrations appropriate for antibiotic lock therapy. J Antimicrob Chemother 2005; 56: 951-3.